SCHEMBL25827873

SCHEMBL25827873

COc1ccc(CN(Cc2ccc(C=O)cc2)C(=O)CBr)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.53
▸ CYP2A6 P11509 1/20 0.53
▸ TSHR P16473 2/20 0.49
▸ USP2 O75604 1/20 0.49
▸ HTT P42858 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ SNCA P37840 1/20 0.46
▸ TSPO P30536 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ TDP1 Q9NUW8 3/20 0.44
▸ ALOX5 P09917 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ GSK3B P49841 2/20 0.43
▸ HDAC3 O15379 1/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ HDAC8 Q9BY41 1/20 0.42
▸ G6PC1 P35575 1/20 0.42
▸ TRPM8 Q7Z2W7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25035714 0.90 TSHR (0.57) ALDH1A1TSHRUSP2HTTSMN1; SMN2
SCHEMBL29234307 0.82 MEN1 (0.53) ALDH1A1TSHRUSP2HTTSMN1; SMN2
SCHEMBL29234164 0.79 LPAR1 (0.48) ALDH1A1TSHRUSP2HTTSMN1; SMN2
SCHEMBL6121816 0.77 TSHR (0.73) ALDH1A1TSHRUSP2HTTSMN1; SMN2
SCHEMBL18938857 0.77 ALDH1A1 (0.59) ALDH1A1CYP2A6TSHRSNCATDP1
SCHEMBL6121862 0.76 TSHR (0.58) ALDH1A1TSHRUSP2HTTSMN1; SMN2
SCHEMBL9607336 0.75 ALDH1A1 (0.79) ALDH1A1CYP2A6TSHRSMN1; SMN2TDP1
SCHEMBL6122244 0.74 TSHR (0.65) ALDH1A1TSHRUSP2HTTSMN1; SMN2
SCHEMBL6121660 0.74 TSHR (0.65) ALDH1A1TSHRUSP2HTTSMN1; SMN2
SCHEMBL25143322 0.74 TSHR (0.57) ALDH1A1TSHRUSP2HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023018471-A9 PIPERAZINE-BASED AGONISTS OF LFA-1 AND VLA-4 TEXAS HEART INSTITUTE (US) 2023-07-13 — — WO disclosed
Send feedback